The Quiet Advantage: Why Speaking Less in Meetings Is a Powerful Skill in Pharma

In many pharmaceutical companies, meetings are everywhere. There are project updates, cross-functional discussions, alignment calls, and decision boards. It often feels like a big part of the job is simply attending and talking in meetings. In this environment, there is a quiet skill that is rarely talked about but incredibly valuable: knowing when not to speak.

At first, silence can be misunderstood. People may think that if you are quiet, you are not engaged, not prepared, or not confident. But this is often not true. In reality, choosing to speak only when necessary is a sign of discipline, awareness, and respect (for the topic, for the people in the room, and for time).

When you speak less, you usually listen more. And listening carefully is one of the most important skills in any meeting. It allows you to fully understand what is being said, instead of just waiting for your turn to talk. In complex environments like pharma, where discussions can involve science, regulations, risks, and timelines all at once, this matters a lot. Missing one detail can lead to misunderstandings or wrong decisions.

Speaking only when needed also improves the quality of what you say. Instead of reacting quickly or repeating what others have already mentioned, you take a moment to think: Am I adding something useful? Over time, this creates a strong reputation. People start to notice that when you speak, it is relevant, clear, and helpful. Your words carry more weight because they are not lost in unnecessary noise.

There is also a simple truth: meetings are expensive. They bring together highly trained professionals (scientists, regulatory experts, clinicians, quality specialists) whose time is limited. If everyone speaks without purpose, meetings become longer and less effective. Important points get diluted, and decisions take more time. Being selective about when you contribute helps keep discussions focused and efficient.

This is especially important in regulatory affairs, where precision is critical. Saying something unclear or premature can create confusion or even risk. But this idea is not only for regulatory teams. It applies to every department in pharma. Whether you work in clinical development, manufacturing, quality, medical affairs, or commercial roles, the same principle holds: thoughtful contribution is more valuable than constant talking.

Another benefit of staying quiet at the right moments is that it creates space for others. Not everyone feels comfortable speaking in meetings, especially in large or cross-functional groups. If a few voices dominate the conversation, valuable perspectives may never be shared. By not speaking all the time, you help create a more balanced discussion where different ideas can come forward. This often leads to better decisions.

Of course, this does not mean you should never speak. Silence is not about hiding or avoiding responsibility. It is about being intentional. Before speaking, it can help to ask yourself a few simple questions:

• Is this new information?

• Is it necessary for the discussion?

• Does it help move things forward?

If the answer is yes, then speak clearly and confidently. If not, it is often better to stay silent.

In many workplaces, there is still a belief that speaking more means contributing more. But this is not always true. In fact, the opposite is often the case. People who speak less but with purpose are often seen as more thoughtful, more reliable, and more effective.

In the end, silence in meetings is not about saying nothing. It is about making sure that when you do speak, it truly matters. And in a field like pharma, where clarity, precision, and good decisions are essential, that is a skill worth developing.